Literature DB >> 18598753

Paternal exposure and counselling: experience of a Teratology Information Service.

Marco De Santis1, Elena Cesari, Annafranca Cavaliere, Maria Serena Ligato, Elena Nobili, Daniela Visconti, Alessandro Caruso.   

Abstract

We describe paternal exposure and counselling in a selected population calling to an Italian Teratology Information Service (TIS). The majority of callers asked for paternal drug exposure (76%, drugs except chemotherapy) and treatment for cancer (17%, chemotherapy and/or radiotherapy). Others asked for exposure to diagnostic radiations (4%), recreational drugs (2%) and occupational chemicals (1%). Among paternal drugs neurological compounds, immunosuppressive drugs and antiviral agents were the main reasons for calling. In humans, there are no evidences of birth defects after paternal exposures, but to minimize any possible risk, counselling in men exposed to radio and chemotherapy should recommend delaying conception for at least 3 months after the end of the therapy. Male patients treated with drugs, whose teratogenic potential has been well assessed or suspected for maternal exposure, should be advised to practice effective birth control during therapy and up to one or two cycles of spermatogenesis and to avoid semen contact with vaginal walls during first trimester of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598753     DOI: 10.1016/j.reprotox.2008.06.003

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  4 in total

1.  Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases.

Authors:  Anders Engeland; Tone Bjørge; Anne Kjersti Daltveit; Svetlana Skurtveit; Siri Vangen; Stein Emil Vollset; Kari Furu
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

2.  Investigating paternal preconception risk factors for adverse pregnancy outcomes in a population of internet users.

Authors:  Eleonora Agricola; Francesco Gesualdo; Emanuela Carloni; Angelo D'Ambrosio; Luisa Russo; Ilaria Campagna; Elisabetta Pandolfi; Alberto E Tozzi
Journal:  Reprod Health       Date:  2016-04-14       Impact factor: 3.223

3.  Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.

Authors:  Chiara Pecori; Marta Giannini; Emilio Portaccio; Angelo Ghezzi; Bahia Hakiki; Luisa Pastò; Lorenzo Razzolini; Andrea Sturchio; Laura De Giglio; Carlo Pozzilli; Damiano Paolicelli; Maria Trojano; Maria Giovanna Marrosu; Francesco Patti; Gian Luigi Mancardi; Claudio Solaro; Rocco Totaro; Maria Rosaria Tola; Giovanna De Luca; Alessandra Lugaresi; Lucia Moiola; Vittorio Martinelli; Giancarlo Comi; Maria Pia Amato
Journal:  BMC Neurol       Date:  2014-05-26       Impact factor: 2.474

Review 4.  The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities.

Authors:  Christopher L R Barratt; Lars Björndahl; Christopher J De Jonge; Dolores J Lamb; Francisco Osorio Martini; Robert McLachlan; Robert D Oates; Sheryl van der Poel; Bianca St John; Mark Sigman; Rebecca Sokol; Herman Tournaye
Journal:  Hum Reprod Update       Date:  2017-11-01       Impact factor: 15.610

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.